News Detail
Mumbai, 1 Feb 2024: Roche, the world's top seller of oncology drugs, has raised red flags against the clinical trials conducted by Indian drug maker Zydus Lifesciences on Perjeta (pertuzumab), its popular breast cancer treatment. The Swiss drug maker has alleged that 500 vials of......
View Details
Source : ET HealthWorld
roche
zydus lifesciences
cdsco
perjeta
pertuzumab
dcgi
clinical trials
Related News
- PIL questioning quality of Anti-Rabies Vaccine disposed of by SC (22-01-2025)
- NCB seizes drugs worth more than 14 lakhs in Jaipur, One arrested (21-01-2025)
- Trump withdraws US from WHO (21-01-2025)
- Telangana Officials Raid Illegal De-Addiction Center in Hanumakonda (21-01-2025)
- Major pharmacy benefit managers found by US FTC to have inflated drug prices for a $7.3 billion gain (21-01-2025)
- Agra: Child given expired vaccine, doctor said- a mistake happened (21-01-2025)
- Police Seize Nearly 1,300 Bottles of Codeine Cough Syrup in Abandoned Vehicle (21-01-2025)
- Vaccine sector does not require incentives or breaks but needs relief from rigid price controls: Adar Poonawalla (21-01-2025)
- CSIR-IIIM Hosts Groundbreaking Workshop on Herbal Medicine Production (21-01-2025)
- 530 Sedative Pills seized from Nalagarh resident (21-01-2025)